EDGC is the international joint venture established in 2013 between EONE Laboratories and Diagnomics, listed on KOSDAQ in 2018. EDGC has developed leading-edge technology for genome analysis through constant research and development and has established business network to expand its influence to the global market.

EDGC diagnoses various diseases over the entire life cycle and provides clinical solution for precision and personalized medicine. Also, EDGC has acquired international and domestic certificates to provide reliable services to customers, i.e. CLIA, CAP, CE. ISO13485 etc.

Furthermore, EDGC has worked on global projects with the most influential Bio-Tech and IT companies in the world such as Illumina and Microsoft. In addition, EDGC is participating as the ONLY Asian partner of the GSA Consortium in which only 12 other global leading companies participate in.

Finally, EDGC will become the company creating healthy and happy life and better future for the people.